ANATOMICAL DISTRIBUTION AND FUNCTION OF DOPAMINE-RECEPTORS IN THE KIDNEY

被引:139
作者
LOKHANDWALA, MF [1 ]
AMENTA, F [1 ]
机构
[1] UNIV ROMA TOR VERGATA, DIPARTIMENTO SANITA PUBBLICA & BIOL CELLULARE, ROME, ITALY
关键词
DOPAMINE; DA-1; RECEPTORS; DA-2; RENAL FUNCTION; HYPERTENSION; RENAL FAILURE; CELLULAR SIGNALING;
D O I
10.1096/fasebj.5.15.1683844
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dopamine receptors of DA-1 and DA-2 subtypes are localized in various regions within the kidney including the renal vasculature (DA-1) as well as sympathetic nerve terminals innervating the renal blood vessels (DA-2). More recent studies using receptor-ligand binding and receptor autoradiography have shown that DA-1 receptors are localized at both the luminal and basolateral membranes at the level of the proximal tubules. Activation of these DA-1 receptors by dopamine and by selective DA-1 receptor agonists results in natriuresis and diuresis. The cellular signaling mechanisms responsible for this response appear to be DA-1 receptor-induced activation of adenylate cyclase and phospholipase C, which via the generation of various intracellular messenger systems cause inhibition of Na+-H+ antiport (luminal) and Na+, K+-ATPase (basolateral), respectively. Both of these events consequently inhibit sodium reabsorption leading to natriuresis and diuresis. It is also known that dopamine can be synthesized within proximal tubular cells from L-dopa, which is taken up from the tubular lumen, and this locally produced dopamine plays an important role in the regulation of sodium excretion particularly during increases in sodium intake. Furthermore, a defect in the renal dopaminergic mechanism may be one of the pathogenic factors in certain forms of hypertension. Finally, whereas DA-1 receptor agonists are shown to be of therapeutic benefit in the treatment of hypertension, heart failure, and acute renal failure, some selective DA-2 receptor agonists are effective antihypertensive agents.
引用
收藏
页码:3023 / 3030
页数:8
相关论文
共 67 条
[31]  
GOLDBERG LI, 1972, PHARMACOL REV, V24, P1
[32]   URINARY-EXCRETION OF DIHYDROXYPHENYLALANINE AND DOPAMINE DURING ALTERATIONS OF DIETARY SALT INTAKE IN HUMANS [J].
GOLDSTEIN, DS ;
STULL, R ;
EISENHOFER, G ;
GILL, JR .
CLINICAL SCIENCE, 1989, 76 (05) :517-522
[33]  
HEGDE S S, 1989, FASEB Journal, V3, pA895
[34]  
HEGDE SS, 1989, J PHARMACOL EXP THER, V251, P1237
[35]   ROLE OF KIDNEY DOPAMINE IN THE NATRIURETIC RESPONSE TO VOLUME EXPANSION IN RATS [J].
HEGDE, SS ;
JADHAV, AL ;
LOKHANDWALA, MF .
HYPERTENSION, 1989, 13 (06) :828-834
[36]  
HIEBLE JP, 1990, CARDIOVASCULAR FUNCT
[37]   THE PATHOPHYSIOLOGICAL ROLE OF RENAL DOPAMINERGIC ACTIVITY IN PATIENTS WITH ESSENTIAL-HYPERTENSION [J].
IIMURA, O ;
YAMAJI, I ;
KIKUCHI, K ;
SHIBATA, S ;
NISHIMURA, M ;
NOZAWA, A ;
AOKI, K ;
HASEGAWA, T ;
KOBAYAKAWA, H ;
KOMURA, H .
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1987, 51 (10) :1232-1240
[38]   RENAL HEMODYNAMICS AND NATRIURESIS INDUCED BY THE DOPAMINE-1 AGONIST, SKF-82526 [J].
JOSE, PA ;
EISNER, GM ;
ROBILLARD, JE .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1987, 294 (03) :181-186
[39]   DEFECTIVE DOPAMINE-1 RECEPTOR ADENYLATE-CYCLASE COUPLING IN THE PROXIMAL CONVOLUTED TUBULE FROM THE SPONTANEOUSLY HYPERTENSIVE RAT [J].
KINOSHITA, S ;
SIDHU, A ;
FELDER, RA .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) :1849-1856
[40]   DOPAMINE AND THE KIDNEY [J].
LEE, MR .
CLINICAL SCIENCE, 1982, 62 (05) :439-448